Partial dysfunction of Treg activation in sickle cell disease.

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Sickle cell disease (SCD) is a chronic inflammatory condition leading to organ damage, anemia, and infections.
• SCD patients frequently develop alloimmunization against red blood cells (RBCs) after transfusions and are prone to autoimmune diseases.
• Regulatory T cells (Treg) are implicated in RBC alloimmunization, based on mouse model studies.

Purpose of the Study:

• To characterize the phenotype and function of regulatory T cells (Treg) in transfused sickle cell disease (SCD) patients.
• To determine if observed Treg differences are related to SCD itself or alloimmunization status.

Main Methods:

• Phenotypic and functional characterization of Treg subpopulations in a cohort of transfused SCD patients.
• Comparison of Treg profiles between SCD patients and healthy blood donors.
• In vitro assessment of Treg phenotype and function using autologous feeder cells in relation to alloimmunization response.

Main Results:

• Significant differences in Treg subpopulation distribution were observed between SCD patients and healthy donors.
• SCD patients exhibit a unique Treg phenotype characterized by strong CTLA-4 and CD39 expression, and weak HLA-DR and CCR7 expression.
• The observed Treg phenotype in SCD patients was associated with the disease, not the alloimmunization status.

Conclusions:

• Sickle cell disease is associated with a distinct regulatory T cell (Treg) phenotype.
• This Treg phenotype is linked to sickle cell disease, independent of alloimmunization.
• Findings provide insights into the immune dysregulation in SCD and its potential impact on transfusion outcomes.